NeoSynBio

Business Services · Australia · 1-10 Employees

View Company Info for Free

Overview

Headquarters

Australia

Revenue

<$5 Million

Industry

Business Services Organizations Research & Development Non-Profit & Charitable Organizations
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About NeoSynBio

NeoSynBio is dedicated to addressing the global scarcity of medical supplies by facilitating access to functional intellectual property for both public and private sector operators, enabling the delivery of safe and affordable medicines. The organization also focuses on educating a new generation of synthetic biologists worldwide, promoting the free exchange of ideas to advance humanity. Through initiatives like the Open Insulin Project, NeoSynBio collaborates with community biolabs globally to develop protocols for the generic production of insulin, aiming to disrupt the pharmaceutical industry's pricing models. Their mission encompasses a commitment to open science and the democratization of biotechnological knowledge.Explore more
NeoSynBio's Social MediaPopular SearchesNeoSynBioNeo Syn BioSIC Code 87,873NAICS Code 54,541Show more

NeoSynBio Org Chart

PhoneEmail
AK
Australia flag for contact location.

Founding Director

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is NeoSynBio your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to NeoSynBio

Compare insights from companies similar to NeoSynBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

NeoSynBio

<$5M
1-10
Private
-
2018
AK
Alex KellyFounding Director
$5.1M
11-50
Public
$14M
2014
Donna Skerrett, Chief Medical Officer at Paradigm Biopharmaceuticals
Donna SkerrettChief Medical Officer
<$5M
11-50
Private
-
2016
CJ
Chacko JosephDrug Development Head
<$5M
1-10
Private
$20M
2019
<$5M
1-10
Private
-
2016
Herbert Treutlein, Co-Founder & Director at SANOOSA
Herbert TreutleinCo-Founder & Director
<$5M
1-10
Private
-
2017
<$5M
1-10
Public
-
2002
HM
Harvey MotulskyStatistics Editor
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

NeoSynBio is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

NeoSynBio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NeoSynBio.

NeoSynBio Tech Stack

A closer look at the technologies used by NeoSynBio

Top Business Services Companies

Frequently Asked Questions Regarding NeoSynBio

What is NeoSynBio's official website?
NeoSynBio's official website is www.neosynbio.com
What is NeoSynBio's Revenue?
NeoSynBio's revenue is <$5 Million
What is NeoSynBio's SIC code?
NeoSynBio's SIC: 87,873
What is NeoSynBio's NAICS code?
NeoSynBio's NAICS: 54,541
How many employees does NeoSynBio have?
NeoSynBio has 1-10 employees
What industry does NeoSynBio belong to?
NeoSynBio is in the industry of: Business Services, Organizations, Research & Development
What is NeoSynBio competition?
NeoSynBio top competitors include: Anaxis Pharma, Molecular Pharmacology, Kira Biotech, BioCurate
What technology does NeoSynBio use?
Some of the popular technologies that NeoSynBio uses are: NS1, Squarespace Online Stores, Adobe Typekit, YouTube
What does NeoSynBio do?

NeoSynBio is dedicated to addressing the global scarcity of medical supplies by facilitating access to functional intellectual property for both public and private sector operators, enabling the delivery of safe and affordable medicines. The organization also focuses on educating a new generation of synthetic biologists worldwide, promoting the fre... e exchange of ideas to advance humanity. Through initiatives like the Open Insulin Project, NeoSynBio collaborates with community biolabs globally to develop protocols for the generic production of insulin, aiming to disrupt the pharmaceutical industry's pricing models. Their mission encompasses a commitment to open science and the democratization of biotechnological knowledge.Read More

What are NeoSynBio social media links?
NeoSynBio Linkedin page NeoSynBio Twitter page NeoSynBio Facebook page
Is NeoSynBio a public company?
NeoSynBio is private company therefore does not currently have an official ticker symbol
See more information about NeoSynBio

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.